Varian Medical Systems selected for new proton therapy centre

Mannheimer Swartling has assisted Varian Medical Systems in entering into agreements for delivery of a proton therapy system to Skandionkliniken. The agreements include supply of an estimated USD 60 million in products. Varian Medical Systems will also have a five year service agreement valued at approximately USD 25 million. Skandionkliniken is the first clinical centre for proton therapy in Scandinavia and will have a capacity of treating 1,000 – 2,500 cancer patients per year. Varian Medical Systems is the world’s leading manufacturer of medical devices and software for treating cancer.

Mannheimer Swartling’s team was led by Bo Söderberg and Klas Wennström who were assisted mainly by Frida Fexler and Ola Ihse.

Our website uses cookies

We use cookies on our website to improve the quality of your browsing experience. A cookie is a text file that is stored on your computer or mobile device. Information about the types of cookies we use and how you can disable them is provided via the link below. We recommend that you read this information before making your selection. If you do decide not to approve of our use of cookies, some parts of the web site may not function as well as if you choose to do so. If you choose to not accept cookies then you answer will be saved for seven days, after that time period you will get a new question regarding accepting cookies.

Please read more about the cookies we use before making your selection.